Valproic acid attenuates the multiple-organ dysfunction in a rat model of septic shock

Chinese Medical Journal

Volumn 123, Issue 19, 2010, Pages 2682-2687

  Shang, You ^a   Jiang, Yuan Xu ^a   Ding, Ze Jun ^a   Shen, Ai Ling ^a   Xu, San Peng ^a   Yuan, Shi Ying ^a   Yao, Shang Long ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acetylation; Inflammation; Septic shock; Valproic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; HISTONE H3; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; NITROGEN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; VALPROIC ACID;

ACETYLATION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD GAS ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; HISTOPATHOLOGY; HOMEOSTASIS; KIDNEY INJURY; KIDNEY PARENCHYMA; LIVER INJURY; LIVER PARENCHYMA; LUNG INJURY; LUNG PARENCHYMA; MALE; MULTIPLE ORGAN FAILURE; NITROGEN URINE LEVEL; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; RAT; SEPTIC SHOCK; TISSUE LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; BLOTTING, WESTERN; DRUG-INDUCED LIVER INJURY; LUNG INJURY; MALE; MULTIPLE ORGAN FAILURE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, SEPTIC; VALPROIC ACID;

EID: 78149273915     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.19.012     Document Type: Article

References (28)

1. Cinel I, Opal SM. Molecular biology of inflammation and sepsis: a primer. Crit Care Med 2009; 37: 291-304.
2. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001; 276: 36734-36741.
3. Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 2007; 321: 892-901.
4. Glauben R, Batra A, Fedke I, Zeitz M, Lehr HA, Leoni F, et al. Histone hyperacetylation is associated with amelioration of experimental colitis in mice. J Immunol 2006; 176: 5015-5022.
5. Lin T, Chen H, Koustova E, Sailhamer EA, Li Y, Shults C, et al. Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver. Surgery 2007; 141: 784-794.
6. Li Y, Liu B, Sailhamer EA, Yuan Z, Shults C, Velmahos GC, et al. Cell protective mechanism of valproic acid in lethal hemorrhagic shock. Surgery 2008; 144: 217-224.
7. Shang Y, XU SP, Wu Y, Jiang YX, Wu ZY, Yuan SY, et al. Melatonin reduces acute lung injury in endotoxemic rats. Chin Med J 2009; 122: 1388-1393.
8. Shang Y, Jiang YX, Xu SP, Wu Y, Wu ZY, Yuan SY, et al. Reduction of pulmonary inflammatory response by erythropoietin in a rat model of endotoxaemia. Chin Med J 2009; 122: 834-838.
9. Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 2004; 89: 1358-1367.
10. Sinn DI, Kim SJ, Chu K, Jung KH, Lee ST, Song EC, et al. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation. Neurobiol Dis 2007; 26: 464-472.
11. Gonzales ER, Chen H, Munuve RM, Mehrani T, Nadel A, Koustova E. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock. J Trauma 2008; 65: 554-565.
12. Gonzales E, Chen H, Munuve R, Mehrani T, Britten-Webb J, Nadel A, et al. Valproic acid prevents hemorrhage-associated lethality and affects the acetylation pattern of cardiac histones. Shock 2006; 25: 395-401.
13. Alam HB, Shuja F, Butt MU, Duggan M, Li Y, Zacharias N, et al. Surviving blood loss without blood transfusion in a swine poly-trauma model. Surgery 2009; 146: 325-333.
14. Shults C, Sailhamer EA, Li Y, Liu B, Tabbara M, Butt MU, et al. Surviving blood loss without fluid resuscitation. J Trauma 2008; 64: 629-638.
15. Shang Y, Li X, Prasad P, Xu S, Yao S, Liu D, et al. Erythropoietin attenuates lung injury in lipopolysaccharide treated rats. J Surg Res 2009; 155: 104-110.
16. Zhang Z, Zhang ZY, Fauser U, Schluesener HJ. Valproic acid attenuates inflammation in experimental autoimmune neuritis. Cell Mol Life Sci 2008; 65: 4055-4065.
17. Peng GS, Li G, Tzeng NS, Chen PS, Chuang DM, Hsu YD, et al. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia. Brain Res Mol Brain Res 2005; 134: 162-169.
18. Marumo T, Hishikawa K, Yoshikawa M, Hirahashi J, Kawachi S, Fujita T. Histone deacetylase modulates the proinflammatory and fibrotic changes in tubulointerstitial injury. Am J Physiol Renal Physiol 2010; 298: F133-F141.
19. Saha RN, Pahan K. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 2006; 13: 539-550.
20. Hamon MA, Batsché E, Régnault B, Tham TN, Seveau S, Muchardt C, et al. Histone modifications induced by a family of bacterial toxins. Proc Natl Acad Sci USA 2007; 104: 13467-13472.
21. Adcock IM. HDAC inhibitors as anti-inflammatory agents. Br J Pharmacol 2007; 150: 829-831.
22. Leoni F, Zaliani A, Bertolini G, Porro G, Pagani P, Pozzi P, et al. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci USA 2002; 99: 2995-3000.
23. Choi Y, Park SK, Kim HM, Kang JS, Yoon YD, Han SB, et al. Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model. Exp Mol Med 2008; 40: 574-581.
24. Bode KA, Schroder K, Hume DA, Ravasi T, Heeg K, Sweet MJ, et al. Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment. Immunology 2007; 122: 596-606.
25. Kostrouchová M, Kostrouch Z, Kostrouchová M. Valproic acid, a molecular lead to multiple regulatory pathways. Folia Biol (Praha) 2007; 53: 37-49.
26. Dugo L, Collin M, Allen DA, Patel NS, Bauer I, Mervaala EM, et al. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Crit Care Med 2005; 33: 1903-1912.
27. Finkelstein RA, Li Y, Liu B, Shuja F, Fukudome E, Velmahos GC, et al. Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock. J Surg Res 2010; 163: 146-154.
28. Li Y, Liu B, Fukudome EY, Kochanek AR, Finkelstein RA, Chong W, et al. Surviving lethal septic shock without fluid resuscitation in a rodent model. Surgery 2010; 148: 246-254.